Nomogram-based prediction of survival in patients with advanced oesophagogastric adenocarcinoma receiving first-line chemotherapy: a multicenter prospective study in the era of trastuzumab

Autor: Custodio, A., Carmona-Bayonas, A., Jimenez-Fonseca, P., Sanchez, M. L., Viudez, A., Hernandez, R., Cano, J. M., Echavarria, I., Pericay, C., Mangas, M., Visa, L., Buxo, E., Garcia, T., Rodriguez Palomo, A., Alvarez Mancenido, F., Lacalle, A., Macias, I., Azkarate, A., Ramchandani, A., Fernandez Montes, A., Lopez, C., Longo, F., Sanchez Bayona, R., Limon, M. L., Diaz-Serrano, A., Hurtado, A., Madero, R., Gomez, C., Gallego, J., AGAMENON Study Grp

Publikováno v: British Journal of Cancer
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid

Background: To develop and validate a nomogram and web-based calculator to predict overall survival (OS) in Caucasian-advanced oesophagogastric adenocarcinoma (AOA) patients undergoing first-line combination chemotherapy. Methods: Nine hundred twenty

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efb15cda09cb8918d970b9a64826b3b4
http://europepmc.org/articles/PMC5518851